Alora Pharmaceuticals Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Employees
  • 9
Employees
  • Latest Deal Type
  • Debt - PPP
  • Financing Rounds
  • 3
  • Investments
  • 1

Alora Pharmaceuticals General Information

Description

Developer and manufacturer of pharmaceutical products. The company's pharmaceutical products primarily include prenatal vitamins, nutraceuticals, dermatologic and other related products for the treatment of gastroenterology and endocrinology disorders.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Debt Financed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • 1880 Mcfarland Parkway
  • Suite 110
  • Alpharetta, GA 30005
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Alora Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Alora Pharmaceuticals‘s full profile, request access.

Request a free trial

Alora Pharmaceuticals Executive Team (3)

Name Title Board Seat Contact Info
Art Deas Chief Executive Officer
Scott Lindler Chief Financial Officer
You’re viewing 2 of 3 executive team members. Get the full list »

Alora Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alora Pharmaceuticals Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 0000 30-Aug-2021 0000000000 00000 Pharmaceuticals 000 0000
To view Alora Pharmaceuticals’s complete acquisitions history, request access »